Durham, N.C., USA - November 5, 2014, Durham, N.C., USA - Chimerix, Inc., a biopharmaceutical company, appoints Peter Payne as SVP of business development and corporate strategy, and Roberto Guzman as VP of corporate compliance.
Article continues below
Mr. Payne brings to Chimerix broad and significant experience in the pharmaceutical, diagnostics and contract research industries where he has held a number of senior management and business development positions in the United States and Europe.
Mr. Payne most recently served as a strategy consultant to Quantum Leap Healthcare, a California non-profit that has developed an innovative approach to accelerating the regulatory approval process for new drugs for the treatment of breast cancer, and was the co-founder and CEO of eXcelerate Research.
He previously served as Vice President, Corporate Development at Quintiles, and held senior roles at Wellcome Research Labs, Sterling Drug and Glaxo Group Research.
Mr. Payne holds an Honors Degree in Pharmacology from the University of Manchester, UK and has completed post-graduate training at the University of North Carolina and the University of Chicago Graduate School of Business.
Mr. Guzman will provide Chimerix with a wide range of experience in legal, regulatory affairs, and Quality Assurance/Quality Control. He has been responsible for the implementation and management of GXP quality and regulatory systems for start-up companies, negotiation of critical MSAs, and management of PreApproval and GMP inspections by US FDA and international agencies such as China FDA, and European Medicines Agency (EMA) and has implemented programs on corporate ethics and grants management.
Mr. Guzman most recently served as Corporate Regulatory Affairs Director at Smith and Nephew where he was responsible for global regulatory affairs and quality assurance. He previously held positions in Regulatory and Quality Control at Cleveland Biolabs, Inc., Inspire Pharmaceuticals, Biomerieux North America, and Novartis-Ciba Vision Division. ■